skip to main content
Idioma:
Refinado por: assunto: Medical Sciences remover Diabetes Care remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects
Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects
Material Type:
Artigo 		Adicionar ao Meu Espaço

Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects

LOPES-VIRELLA, Maria F ; BAKER, Nathaniel L ; HUNT, Kelly J ; CLEARY, Patricia A ; KLEIN, Richard ; VIRELLA, Gabriel

Diabetes care, 2013-08, Vol.36 (8), p.2317-2323 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
2
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications

Lopes-Virella, Maria F ; Carter, Rickey E ; Gilbert, Gregory E ; Klein, Richard L ; Jaffa, Miran ; Jenkins, Alicia J ; Lyons, Timothy J ; Garvey, W. Timothy ; Virella, Gabriel

Diabetes care, 2008-10, Vol.31 (10), p.2006-2012 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
3
High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes
High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes

Lopes-Virella, Maria F ; Baker, Nathaniel L ; Hunt, Kelly J ; Lyons, Timothy J ; Jenkins, Alicia J ; Virella, Gabriel

Diabetes care, 2012-06, Vol.35 (6), p.1333-1340 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
4
The Long-Term Effects of Type 1 Diabetes Treatment and Complications on Health-Related Quality of Life: A 23-year follow-up of the Diabetes Control and Complications/ Epidemiology of Diabetes Interventions and Complications cohort
The Long-Term Effects of Type 1 Diabetes Treatment and Complications on Health-Related Quality of Life: A 23-year follow-up of the Diabetes Control and Complications/ Epidemiology of Diabetes Interventions and Complications cohort
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Long-Term Effects of Type 1 Diabetes Treatment and Complications on Health-Related Quality of Life: A 23-year follow-up of the Diabetes Control and Complications/ Epidemiology of Diabetes Interventions and Complications cohort

JACOBSON, Alan M ; BRAFFETT, Barbara H ; CLEARY, Patricia A ; GUBITOSI-KLUG, Rose A ; LARKIN, Mary E

Diabetes care, 2013-10, Vol.36 (10), p.3131-3138 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
5
The Association of Skin Intrinsic Fluorescence With Type 1 Diabetes Complications in the DCCT/EDIC Study
The Association of Skin Intrinsic Fluorescence With Type 1 Diabetes Complications in the DCCT/EDIC Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Association of Skin Intrinsic Fluorescence With Type 1 Diabetes Complications in the DCCT/EDIC Study

ORCHARD, Trevor J ; LYONS, Timothy J ; VILLAVICENCIO, Stephan ; CLEARY, Patricia A ; BRAFFETT, Barbara H ; MAYNARD, John ; COWIE, Catherine ; GUBITOSI-KLUG, Rose A ; WAY, Jeff ; ANDERSON, Karen ; BARNIE, Annette

Diabetes care, 2013-10, Vol.36 (10), p.3146-3153 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
6
Intensive Treatment of Diabetes Is Associated With a Reduced Rate of Peripheral Arterial Calcification in The Diabetes Control and Complications Trial
Intensive Treatment of Diabetes Is Associated With a Reduced Rate of Peripheral Arterial Calcification in The Diabetes Control and Complications Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intensive Treatment of Diabetes Is Associated With a Reduced Rate of Peripheral Arterial Calcification in The Diabetes Control and Complications Trial

Carter, Rickey E ; Lackland, Daniel T ; Cleary, Patricia A ; Yim, Eunsil ; Lopes-Virella, Maria F ; Gilbert, Gregory E ; Orchard, Trevor J

Diabetes care, 2007-10, Vol.30 (10), p.2646-2648 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
7
Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes: A BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy
Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes: A BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes: A BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy

Schneider, David J ; Hardison, Regina M ; Lopes, Neuza ; Sobel, Burton E ; Brooks, Maria Mori

Diabetes care, 2009-05, Vol.32 (5), p.944-949 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
8
Platelet plasminogen activator inhibitor 1 in patients with type II diabetes
Platelet plasminogen activator inhibitor 1 in patients with type II diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Platelet plasminogen activator inhibitor 1 in patients with type II diabetes

JOKI, R ; LAIMINS, M ; KLEIN, R. L ; LYONS, T. J ; LOPES-VIRELLA, M. F ; COLWELL, J. A

Diabetes care, 1994-08, Vol.17 (8), p.818-823 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
9
Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes
Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes

Jokl, R ; Klein, R L ; Lopes-Virella, M F ; Colwell, J A

Diabetes care, 1995-08, Vol.18 (8), p.1150-1155 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.